TMS Therapy may be an appropriate depression treatment option for a broad range of adult patients who:
- Are in a recurrent episode
- Have attempted multiple depression medications yet are still symptomatic
- Are considering a complex, multi-drug regimen (eg, adding an atypical antipsychotic) but concerned about side effects
- Are highly motivated to get well
After first-line treatment attempts with antidepressant medication, patients are often forced to pursue more pharmacotherapy. Few depression treatment options have been studied and approved by the FDA for use in patients who have not benefited from prior antidepressant treatment. As medication increases, so can side effects and the potential for treatment failure. Additionally, long-term use of antidepressants can cause more severe side effect that may be irreversible.
TMS—Is An Appropriate Option for Depression Treatment
In the 3rd edition of Practice Guidelines for the Treatment of Patients with Major Depression (2010), the American Psychiatric Association (APA) cited TMS as an appropriate treatment option for depression patients who have not benefited from initial antidepressant pharmacotherapy.
NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.
NeuroStar TMS Therapy is only available by prescription. A doctor can help decide if NeuroStar TMS Therapy is right for you.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of NeuroStar TMS (<0.1% per patient).
NeuroStar TMS Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment.